TGF-Beta Inhibitor (Tampereen Korkeakoulusäätiö)

N/A

Report date: 2025/01/26 17:33:36

Base Information

Drug NameTGF-Beta Inhibitor (Tampereen Korkeakoulusäätiö)
Drug Alias NameDCN-tCRKhuman decorin fused to truncated homing peptide CRK (Tampereen Korkeakoulusäätiö)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTransforming growth factor beta receptors antagonists
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTampereen Korkeakoulusäätiö Sr
China Registration ClassN/A

Develop Information

Active CompaniesTampereen Korkeakoulusäätiö Sr
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A